Aripiprazole - Bristol-Myers Squibb/Otsuka Pharmaceutical
At a glance
- Drug Originator Otsuka Pharmaceutical
- Drug Licenced by Bristol-Myers Squibb; Lundbeck A/S
- Drug Class Antidepressants; Antipsychotics; Behavioural disorder therapies; Chlorobenzenes; Mood stabilisers; Piperazines; Quinolines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Dopamine D2 receptor partial agonists; Dopamine D3 receptor antagonists; Dopamine D4 receptor antagonists; Histamine H1 receptor antagonists; Serotonin 1A receptor partial agonists; Serotonin 2C receptor partial agonists; Serotonin 5-HT2A receptor antagonists; Serotonin 7 receptor antagonists
- USA Patent Applicants OTSUKA
- USA Patents 41
- NDAs 5
- International Patents 399
- Patent Applications 4,953
Disclaimer